{"prompt": "['Alliance A221504', '83. Cain DM, Vang D, Simone DA, Hebbel RP, Gupta K. Mouse models for studying pain in sickle disease:', 'effects of strain, age, and acuteness. Br J Haematol. 2012;156(4):535-544.', '84. Michaels LA, Ohene-Frempong K, Zhao H, Douglas SD. Serum levels of substance P are elevated in', 'patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood.', '1998;92(9):3148-3151.', '85. Vincent L, Vang D, Nguyen J, et al. Mast cell activation contributes to sickle cell pathobiology and', 'pain in mice. Blood. 2013;122(11):1853-1862.', '86. Vincent L, Vang D, Nguyen J, Benson B, Lei J, Gupta K. Cannabinoid receptor-specific mechanisms', 'to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic', 'inflammation. Haematologica. 2015.', '87. Wu TT, Wang ZG, Ou WL, et al. Intravenous flurbiprofen axetil enhances analgesic effect of opioids', 'in patients with refractory cancer pain by increasing plasma beta-endorphin. Asian Pac J Cancer Prev.', '2014;15(24): 10855-10860.', '88. Weber ML, Chen C, Li Y, et al. Morphine stimulates platelet-derived growth factor receptor-beta', 'signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo. Br J Anaesth.', '2013;111(6):1004-1012.', '89. Gammaitoni AR, Fine P, Alvarez N, McPherson ML, Bergmark S. Clinical application of opioid', 'equianalgesic data. Clin J Pain. 2003;19(5):286-297.', '90.', 'Walker PW, Palla S, Pei BL, et al. Switching from methadone to a different opioid: what is the', 'equianalgesic dose ratio? J Palliat Med. 2008; 1(8): 1103-1108.', '91.', 'Ripamonti C, De Conno F, Groff L, et al. Equianalgesic dose/ratio between methadone and other opioid', 'agonists in cancer pain: comparison of two clinical experiences. Ann Oncol. 1998;9(1):79-83.', '92. Hari M Danielle, et al. AJCC Cancer Staging Manual 7th Edition Criteria for Colon Cancer: Do the', 'Complex Modifications Improve Prognostic Assessment? J Clin Oncol. 2013:217(2):181-190', '93. Efficace F, Bottomley A, Smit EF, Lianes P, Legrand C, Debruyne C, Schramel F, Smit HJ, Gaafar', 'R, Biesma B, Manegold C, Coens C, Giaccone G, Van Meerbeeck J, Group ELC and Quality of Life', \"U. Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-\", 'small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.', 'Ann Oncol. 2006;17:1698-1704.', '94. Zhang YF, Xu QX, Liao LD, Xu XE, Wu JY, Wu ZY, Shen JH, Li EM and Xu LY. Association of', 'mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma.', 'Dis Esophagus. 2015;28:196-203.', '95. Yao YS, Yao RY, Zhuang LK, Qi WW, Lv J, Zhou F, Qiu WS and Yue L. MOR1 expression in', 'gastric cancer: a biomarker associated with poor outcome. Clin Transl Sci. 2015;8:137-142.', '62', 'Update 2', 'Version Date 6/25/2019']['Alliance A221504', '17.0 MODEL CONSENT FORM', 'Study Title for Study Participants: Testing the addition of naloxegol', '(Movantik\u00ae) or placebo to anti-cancer therapy in advanced lung cancer', 'Official Study Title for Internet Search on http://www.ClinicalTrials.gov:', 'A Randomized, Double-Blind, Placebo-Controlled Pilot Study Of An Oral,', 'Selective Peripheral Opioid Receptor Antagonist In Advanced Non-Small Cell', 'Lung Cancer', 'What is the usual approach to my lung cancer?', 'You are being asked to take part in this study because you have been diagnosed with a common', 'type of advanced lung cancer (non-small cell lung cancer: NSCLC). You have also used pain', 'medicines (such as morphine or similar drugs, called opioids) in the past 4 weeks to control pain', 'caused by your cancer. People who are not in a study are usually treated with a variety of FDA-', 'approved medications. Many patients with advanced lung cancer also require opioid pain', 'medications to control pain at some time during the course of their disease.', 'What are my other choices if I do not take part in this study?', 'If you decide not to take part in this study, you have other choices. For example:', 'you may choose to have the usual approach described above', 'you may choose to take part in a different study, if one is available', 'or you may choose not to be treated for cancer but you may want to receive comfort', 'care to relieve symptoms.', 'Why is this study being done?', 'You have advanced lung cancer and will be receiving opioids to relieve some of the cancer-', 'related pain that you are experiencing. Opioids relieve pain through their action inside the brain.', 'However, by their action outside of the brain, opioid medications can cause unwanted side', 'effects such as constipation, nausea, vomiting, dry mouth, and problems passing urine.', 'The purpose of this study is to test the safety and effects of naloxegol. Naloxegol is a medicine', 'that blocks the actions of opioids outside the brain, without interfering with the pain-relieving', 'effect of opioids inside the brain. The researchers want to see if naloxegol will relieve some of the', 'side effects of the opioid pain medications you are taking. They also want to see if naloxegol fights', 'off future growth in the cancer that you have, whether or not you are taking pain medications.', 'The effect of two different doses of naloxegol will be compared to placebo. A placebo is a pill', 'that looks like the study drug but contains no medication.', '63', 'Update 2', 'Version Date 6/25/2019']\n\n###\n\n", "completion": "END"}